EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats

Maria Szighardtova iD, Silvia Aziriova, Peter Stanko iD, Kristina Repova iD, Tomas Baka iD, Kristina Krajcirovicova, Stefan Zorad, Michaela Adamcova iD, Peter Sabaka iD, Veronika Borbélyová iD, Fedor Simko

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262210905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Szighardtova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathophysiology, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Valsartan, Captopril, Ivabradine, Anxiety. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic, grant number VEGA 1/0048/23, and the Slovak Resea…, The Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic, the Slovak Research and Development Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disorders and the medications used to treat them can affect physiological patterns of behavior. The aim of the present study was to determine whether the dual inhibition of neprilysin and angiotensin II—sacubitril/valsartan (ARNI) can modify anxiety-like behavior in male spontaneously hypertensive rats (SHR). We compared ARNI with two other drugs in the portfolio of heart failure treatment, captopril and ivabradine. Six groups (n = 13) of 12-week-old rats were treated for six weeks: control (Wistar rats), control + ARNI, SHR, SHR + ARNI, SHR + captopril, and SHR + ivabradine. The elevated plus maze test, the open field test, and the light–dark box test were used to determine anxiety-like behavior. SHRs exhibited higher systolic blood pressure (SBP), heart rate (HR), left ventricular weight (LVW), and hydroxyproline concentration (LVHP) but displayed a reduced level of anxiety-like behavior in comparison to controls. ARNI reduced SBP, HR, and LVW but had no significant effect on the level of anxiety in SHR, and similar results were achieved by captopril and ivabradine. Additionally, correlation analysis indicated that anxiety-like behavior in Wistar rats or SHR, either with or without cardiovascular therapy, was independent of SBP, HR, LVW, or LVHP. The level of anxiety-like behavior can, therefore, be considered part of the inherent neurobehavioral traits unrelated to fundamental hemodynamic or structural cardiovascular parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValsartanCaptoprilIvabradineAnxietyBiphenyl CompoundsAminobutyratesHypertensionBehavior, AnimalTetrazolesAnimalsRats, Inbred SHRMaleRatsDrug CombinationsBlood PressureRats, WistarHeart RateNeprilysin

Stichwörter der Autor:innen

anxietyblood pressurecaptoprilcorrelation analysisheart rateivabradinesacubitril/valsartanspontaneously hypertensive rats

Substanzen

ValsartanCaptoprilIvabradineBiphenyl CompoundsDrug Combinationssacubitril and valsartan sodium hydrate drug combinationAminobutyratesNeprilysinTetrazoles

Autor:innen und Institutionen

  • Institute of Pathophysiology, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia.
  • Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, 845 05 Bratislava, Slovakia.
  • Department of Physiology, Faculty of Medicine, Charles University, 500 03 Hradec Kralove, Czech Republic.
  • Department of Infectiology and Geographical Medicine, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovakia.
  • Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia.
  • 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, 833 05 Bratislava, Slovakia.

ORCID-Profile: Maria Szighardtova, Peter Stanko, Kristina Repova, Tomas Baka, Michaela Adamcova, Peter Sabaka, Veronika Borbélyová

Förderung

  • The Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic, grant number VEGA 1/0048/23, and the Slovak Resea…
  • The Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic
  • the Slovak Research and Development Agency

Zitieren

APA

Szighardtova, M., Aziriova, S., Stanko, P., Repova, K., Baka, T., Krajcirovicova, K., Zorad, S., Adamcova, M., Sabaka, P., Borbélyová, V., & Simko, F. (2025). Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210905

Vancouver

Szighardtova M, Aziriova S, Stanko P, Repova K, Baka T, Krajcirovicova K, et al. Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210905

BibTeX
@article{Szighardtova2025,
  author = {Szighardtova, Maria and Aziriova, Silvia and Stanko, Peter and Repova, Kristina and Baka, Tomas and Krajcirovicova, Kristina and Zorad, Stefan and Adamcova, Michaela and Sabaka, Peter and Borbélyová, Veronika and Simko, Fedor},
  title = {Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262210905}
}
Kostenlos starten →